Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Ceftazidime-Avibactam for Treatment of Complicated Urinary Tract and Intra-Abdominal Infections

Drug Name (Brand / Generic)

Ceftazidime-avibactam

Developed by

Actavis and AstraZeneca

Therapy Class

Non-β lactam β-lactamase inhibitor

Product Description

Antibiotic

Current Indications

Complicated urinary tract infections (cUTI) and complicated intra-abdominal infections (cIAI)

Market Sector

Anti-infectives

Development Status

NDA under review by the US FDA
Expand
Close
Close
Close

Go Top